Atlas Trials

Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome

Clinical trial NCT06797609 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06797609
Sponsor
Mario Negri Institute for Pharmacological Research
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Nephrotic Syndrome
Start date
2025-04-01
Primary completion
2026-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.